Nevro (NYSE: NVRO) is a public multinational medical technology company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform.
We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has impacted the lives of over 28,000 patients around the world.
The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States.
Openings for continuing medical students for up to one year to apply their medical expertise and science background to basic and clinical research and development. The medical student interns will work closely with the advanced technology team to apply emerging technologies to treat pain and non-pain clinical indications in upcoming clinical trials.
Medical students should have a strong background in basic and neural anatomy, gastrointestinal and endocrine physiology, and neuroscience. Clinical exposure in neurosurgery, neurology, and endocrinology is preferred. Students should have a strong background in pharmacology and be able to compare neuromodulation versus traditional pharmacological measures using NNT, NNH, or similar measures for a variety of clinical indications. Students should have a strong interest in applying emerging neuromodulation and other technologies to treat a variety of clinical indications.
Students will be involved in designing and implementing safety and efficacy experiments as well as clinical trial protocols. Students may also be involved technology development projects involving electrical engineering, integrated circuit design, wireless communication, wireless charging, electrochemistry, bioengineering, biochemistry, biomaterials, biosensors, micropackaging, neuroengineering, neurophysiology, neurobiology, signal processing, computational modeling, and materials.